BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to SAS cell line is 32
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and RT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 24475244 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 22692956 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | Cisplatin | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 33238517 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and Western Blotting | NA | 0.48 | 0.5461 | 22422628 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SP assay and Western Blotting | NA | 0.48 | 0.5461 | 23843890 |
| NES | 7756 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0573 | 22692956 |
| NES | 7756 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and Western Blotting | NA | 0.48 | 0.0573 | 22422628 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and RT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 24475244 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 22692956 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | Cisplatin | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 33238517 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 22422628 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SP assay and Western Blotting | NA | 0.48 | 0.6448 | 23843890 |
| HSPA5 | 5238 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA followed by Western Blotting and FACs | NA | 0.4 | 0.0117 | 20979610 |
| HSPA5 | 5238 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | Cisplatin | FACs followed by SFA | NA | 0.4 | 0.0117 | 25217518 |
| HSPA5 | 5238 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | FACs followed by SP assay | NA | 0.4 | 0.0117 | 23843890 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SP assay and Western Blotting | NA | 0.28 | 0.5695 | 23843890 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 29515788 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 22692956 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 24475244 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 25217518 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | ALDEFLUOR assay and SFA | NA | 0.12 | 0.684 | 32357409 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | ALDEFLUOR assay followed by SP assay | NA | 0.12 | 0.684 | 23843890 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and ALDEFLUOR assay | NA | 0.12 | 0.684 | 20979610 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and ALDEFLUOR assay | NA | 0.12 | 0.684 | 22422628 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 21169409 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | FACs | NA | 0.12 | 1 | 29515788 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | FACs followed by SFA | NA | 0.12 | 1 | 22692956 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | FACs followed by SFA | NA | 0.12 | 1 | 24475244 |
| PROM1 | 9454 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | Cisplatin | FACs followed by SFA | NA | 0.12 | 0.7582 | 25217518 |
| PROM1 | 9454 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | FACs followed by SP assay | NA | 0.12 | 0.7582 | 23843890 |
| PROM1 | 9454 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | NA | SFA and FACs | NA | 0.12 | 0.7582 | 20979610 |
| SLC2A3 | 11007 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SAS | Cisplatin | FACs followed by SFA | NA | 0.12 | 0.0042 | 25217518 |